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Objectives. Keratoacanthoma (KA), a keratinocytic neoplasm, is associated with sun exposure and is often found in the head
and neck area, including the lip. KA is thought to arise from hair follicle cells, but its origin is largely unknown. Keratins (Ks)
and histochemical stains are of great value to characterize and identify normal and neoplastic cells. The objective of this study
is to analyze a panel of Ks and periodic acid-Schiff (PAS) staining on KA.
Study Design. Using KA biopsies from the lips and normal skin samples, we performed immunohistochemical and
histochemical profiling to determine which biomarkers are conserved between tumors and normal tissues.
Results. The normal hair follicle has multiple well-defined compartments. The outer root sheath (ORS) cells presented K6 and
K14 and were also PAS positive. In addition, the infundibulum cells showed positive labeling to K10. Hair cortex keratin was
observed in the cortical and precortical cells. Interestingly, KA tumor cells were positive for PAS, K6, K10, and K14 but not to
hair cortex keratin. Lip and skin epithelium were negative for PAS and K6.
Conclusions. Our results indicate that KA of the lip is derived from ORS cells, particularly those cells associated with the
upper ORS. (Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:310-317)Keratoacanthoma (KA) is a self-limiting, benign
epidermal keratinocytic neoplasm often associated with
sun exposure and with occurrence in older individuals.1
KA is commonly found in the head and neck area,
including the vermilion border of the lip. KA can be
diagnostically challenging for clinicians and patholo-
gists because of its rapid growth and histologic pattern.
Particularly during the short proliferative phase, KA
harbors histologic features that resemble well-differen-
tiated squamous cell carcinoma (SCC).1,2 Nevertheless,
KA has distinctive genetic aberrations compared with
squamous cell carcinoma.3-5 KA is often not diagnosed
and treated because it can regress spontaneously,
sometimes in a matter of months. When diagnosed, KA
is often treated with surgical excision.6-8 The diagnosis
of KA is based on microscopic cell morphology and
tissue architecture; currently, little is known about the
origin of KA and the cell types involved in its
formation.1,2Vivian Petersen Wagner and Caroline Siviero Dillenburg made equal
contributions to this article.
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310KA on hair-bearing body sites, such as the hands,
scalp, and auricle, may present as single or multiple
lesions that presumably derive from the hair follicle.1,2
Some believe that KA cells can differentiate into cells
that are similar to outer root sheath cells of the hair
follicle.9 The hair follicle is the major adnexal organ of
mammalian skin characterized by highly organized
tissue architecture and self-renewal features. It is
composed by the germinative matrix, cell-lining dermal
papilla, hair ﬁber or shaft, inner root sheath (IRS), outer
root sheath (ORS), infundibulum, glassy membrane,
and connective tissue sheath.10 This epidermal
appendage is very active during an individual’s life,
passing through continual cycles of proliferation (ana-
gen), regression (catagen), and quiescence (tel-
ogen).11,12 The hair follicle cycle can inﬂuence skin
carcinogenesis.
Special stains have been used to evaluate hair folli-
cles and skin adnexal neoplasms. Among them, peri-
odic acid-Schiff (PAS) stains, with and without
diastase, can be helpful in demonstrating cytoplasmic
glycogen content and stromal hyalinized basement
membrane in cutaneous adnexal lesions. This staining
is widely used to identify the outer root sheath13 and isStatement of Clinical Relevance
A better understanding of keratoacanthomae
forming cells and their markers will greatly
contribute to our knowledge of epithelial tumors.
This information may impact how keratoacanthoma
is diagnosed and treated.
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such as trichilemmoma, which exhibits glycogen-rich
cells.14 Glycogen, identiﬁed by PAS-positive staining,
serves as a storage carbohydrate that is used as a source
of energy by the skin epithelium and its appendages
participating in several important skin functions, kera-
tinization, and the hair cycle.15 Differences in glycogen
metabolism occur during the hair cycle. Growing hair
follicles require more energy than the resting ones.
Particularly, the ORS of hair follicles in the anagen
phase always stores considerable amounts of
glycogen.16
Keratins are scaffolding proteins that form interme-
diate ﬁlament networks in the cytoplasm of epithelial
cells. The main function of keratins is the maintenance
of cell and tissue structure.17,18 Over the years, human
disorders and mouse genetics have shown additional
complex functional roles for cytoskeleton keratins,
which are involved in the modulation apoptosis, cell
growth, tissue polarity, wound response, and tissue
remodeling.17-19 Keratins are encoded by large and
conserved multigene family coding proteins that are
divided into two subgroups based on molecular weight:
(1) the smaller or lower-molecular-weight acidic type I
(40-64 kilodaltons [kDa], with isoelectric point [pI]:
4.7-6.1) and the larger or higher-molecular-weight
neutral-basic type II (52-70 kDa, with pI:5.4-8.4).17,18
The new consensus on the nomenclature for human
keratins is the term keratins or cytokeratins for epithelial
keratins of soft epithelial tissues, such as the epidermis.
Hard epithelial tissues, such as hair and nail, also ex-
press a group of specialized type I and type II keratin
proteins called trichocyte or hair keratins. Each
epithelial cell expresses a proﬁle of keratins that varies
according to the epithelium type, the degree of differ-
entiation, and the pathologic process.17,18,20 On the
basis of these aspects, monospeciﬁc antibodies are
routinely used against keratins to determine tissue-of-
origin and/or differentiation states of tumors.17 Conse-
quently, increased knowledge about the regulatory
functions of keratins and the molecular dissection of the
pathologies may provide important information
regarding the lesion’s origin and behavior, as well as,
potentially new targets for the development of novel
therapeutic strategies for the treatment of epithelial
diseases.17,18,20
KA of the lip is usually a solitary and asymptomatic
circular nodule with a central keratin plug that occurs at
the vermilion border of the lip and spreads over the
adjacent skin.6 The epithelial origin of this type of KA
has not been determined, and an association between KA
of the lip and the hair follicle has not been shown. In order
to understand the histogenesis of KA, we analyzed the
expression of different keratins and PAS staining in KA
and compared them with normal hair follicles.MATERIALS AND METHODS
Tissue samples
KA samples from patients diagnosed between 1996 and
2012 were obtained from the archives of the Laboratory
of Pathology of the Hospital de Clinicas, Porto Alegre,
Brazil (HCPA), and the Oral Pathology Service, School
of Dentistry of Universidade Federal do Rio Grande do
Sul (FO-UFRGS; Human Research Ethics Committee
approval no. 802.108). Nine formalin-ﬁxed and
parafﬁn-embedded tumor specimens from the lip were
identiﬁed. The diagnosis of KA was conﬁrmed by two
pathologists (MDM, CHS), who independently
reviewed the slides stained with hematoxylin and eosin
(H&E). Nine normal human adult skin-bearing hair
follicles were included in the study. In alignment with
classically diagnosed KA, which occurs in patients over
45 years of age, our nine patients ranged in age from 48
to 77 years (mean age 67 years). The majority of the
samples were from Caucasians and the male-to-female
ratio was 1:1.6. The histologic criteria used in the
diagnosis of KA were well-delimited hyperplastic,
crateriform, endophytic or exophytic epithelia with a
central keratin-containing crater (cup-shaped architec-
ture); presence of basaloid layer in proliferating endo-
phytic lobules and a sharp outline between tumor nests
and the stroma; and large cells with prominent nucleoli
and eosinophilic ground-glass cytoplasm with lack of
anaplasia.21,22Immunohistochemistry
Immunohistochemical staining was performed on 3-mm
tissue sections. Sections were deparafﬁnized in xylene,
dehydrated in ethanol of descending grades, microwaved
in 10 mM citric acid (pH 6.0) to recover antigenic sites.
The primary antibodies, clones, dilutions and sources
were as follows: mouse anti-keratin 6 (clone Ks6.KA12,
1:50, Abcam, Boston, MA); mouse anti-hair cortex ker-
atin antibody (AE13) (clone AE13, 1:100; Abcam,
Boston, MA); rabbit anti-keratin 10 (polyclonal, 1:150;
Covance, Princeton, NJ); and rabbit anti-keratin 14
(polyclonal, 1:2500, Covance, Princeton, NJ). Negative
controls were obtained by replacing the primary antibody
with phosphate-buffered saline solution. Slides were
incubated with antibodies overnight at 4C in humid
chambers. The detection system used was the ABC
System (Vector Labs, Burlingame, CA). The sections
were then incubated with diaminobenzidine tetra-
hydrochloride (DAB, Sigma-Aldrich Corp., St. Louis,
MO) and counterstained with Mayer’s hematoxylin.Periodic acid-Schiff (PAS) staining
PAS staining (PAS stain Kit, Richard-Allan Scientiﬁc,
Kalamazoo, MI) was performed on 5-mm sections as
Fig. 1. Normal hair follicle compartments and keratin and PAS labeling. (A, B, and C). Schematic illustrations demonstrating the
compartments of hair follicle structure, which is divided in upper and lower segment (A). Transverse or cross-sections of the hair
follicle show upper segment of permanent infundibulum (B and C). The main components of the upper segment are outer root
sheath (ORS), hair shaft and sebaceous gland (A, B, and D; H&E, 100). Lower segment is mainly composed of ORS, inner root
sheath (IRS), and hair cortex (A and C); H&E, 100). Representative sections showing the upper ORS or infundibulum cells
expressing K6 (E), K10 (F), and K14 (G). The same cells are negative for hair cortex keratin (H) and positive for Periodic
acideSchiff (PAS) staining (100) (I). Lower segment of the hair follicle showing the ORS, IRS, and cortex (H&E, 100) (J). In
this part of the hair follicle, the ORS exhibited positive labeling for K6 (K) but does not express K10 (L). ORS cells express K14
(M). Only the cortex is revealed by hair cortex keratin (N). ORS is PAS-positive (O). (H&E, immunohistochemistry and histo-
chemical reaction 100).
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were deparafﬁnized and hydrated using ethanol di-
lutions and distilled water, they were immerged in 0.5%
PAS solution. Tissue sections were counterstained with
Mayer’s hematoxylin and mounted with synthetic
mount medium.
RESULTS
Outer root sheath is positive for PAS, K6, K10, and
K14
The hair follicle is the major adnexal organ of
mammalian skin and comprises several highly orga-
nized, concentric, and morphologically distinct
compartments.10,11 The major compartments are thehair-forming compartment (e.g., cortex and matrix),
the IRS, and the ORS, as indicated on the represen-
tative section of the hair follicle (Figure 1, AeC).
The upper segment of the hair follicle comprises the
continuation of the outer root sheath toward the
stratiﬁed skin epithelium and is also known as the
upper outer root sheath or infundibulum (Figure 1, A
and B). Hair follicles displayed elaborate programs of
differentiation and consequent keratin expres-
sion,24,25 including K6 and K14 in the ORS, K10 in
the upper ORS (Figure 1, BeH) and hair cortex
keratin in cortical and precortical cells (Figure 1, C,
JeN). The ORS cells are PAS positive (Figure 1,
I and O).
Fig. 2. Keratoacanthomas (KA) are positive for outer root sheath markers Periodic acideSchiff staining, K6, K10, and K14. A,
Representative histologic section depicting the KA tumors with the typical histopathologic features of a central, keratotic, and horn-
ﬁlled crater (H&E, 40). B, Note the sharp demarcation between the tumor and stroma as well as the absence of pleomorphism and
mitosis (white line, insert 100). C, Tumor cells are PAS-positive (PAS, 40), which is evident at high magniﬁcation (D,
insert 100). Tumor cells express K6 (E, F), K10 (G, H), and K14 (I, J), but they are negative for hair cortex keratin (K, L).
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markers, including PAS-positive stain, K6, K10 and
K14, but they do not show hair cortex keratin
The histopathologic features of KA included a central
horn-ﬁlled keratotic crater and a sharp demarcation
between the epithelial tumor cells and stroma. There
were minor cellular and nuclear pleomorphisms and
only few mitosis noted in the lesions (Figure 2, A and
B). Given that KA may originate in the hair follicle, we
analyzed the hair follicle component markers on KA.
We stained the slides with PAS, a well-established
histochemical stain used to analyze glycogen and for
the purpose of histopathologic diagnosis in many
pathologic conditions.15 Interestingly, the ORS of the
normal hair follicle was PAS positive (Figure 1, I and
O), and the epithelial tumor cells within the KA were
also positive for PAS (Figure 2, C and D). Furthermore,
K6 (Figure 2, E and F) and K10 (Figure 2, G and H)
were strongly positive in tumor islands except in cells
in the outer layer of the tumor (Figure 2, F and H,
arrow). All layers of tumor cells exhibited K14 posi-
tivity (Figure 2, I and J). Cells from KA did not express
hair cortex keratin (Figure 2, K and L). The histo-
chemical and immunohistochemical features were
consistent among all KA cases (Table I). Collectively,
our results indicate that KA is positive for ORS bio-
markers. Our results eliminate the participation of
differentiated cells within the matrix and cortex that
forms the hair shaft in the histogenesis of the KA.
Overall, our results indicate that KA has a histogenesis
on the outer root sheath of the hair follicle.Interfollicular epithelium is negative for PAS and K6
Keratin, an intracytoplasmic protein ﬁlament present in
the cytoplasm of the epithelial cells, is responsible forthe function of structural maintenance of the cell and
tissue.10 We analyzed whether keratins used to identify
speciﬁc layers of the hair follicle structure were present
in the neoplasm. Notably, keratins are observed in both
the follicular epithelium and the interfollicular epithe-
lium. Therefore, we analyzed the labeling of K6, K10,
K14, and hair cortex keratin, in addition to PAS
staining, in the adjacent margin (i.e., adjacent epithe-
lium) of the lesion and in distant epithelium as a control
(Figure 3). As expected, PSA-positive staining was
mainly found on the basement membrane of the
epithelium and around the blood vessels (Figure 3, B,
arrow). Epithelial cells on the skin and adjacent lip
mucosa did not express hair cortex keratin (Figure 3, B
and C). Although the epithelium did not show K6
(Figure 3, D), K14 was found in the epithelial basal cell
layer and K10 in the spinous and granular layers
(Figure 3, E and F). Extensive solar elastosis was also
observed in the tissue samples.DISCUSSION
First described in 1950 by Rook and Whimster, KA is a
fast growing tumor that continues to elicit research in-
terest with regard to its etiology, pathogenesis, and
progress, particularly because it can regress spontane-
ously.6,7,26-28 KA has three phases: the initial prolifer-
ative phase, the mature phase, and the resolving
phase.12 KA regression is part of the resolving phase,
during which the central core is shed and the epithelial
cells disappear, leaving behind a healed area. The
regression phase is observed in both human and animal
models of KA.7,29
The biologic behaviors of KA and the hair follicle
share many similarities. Like the three phases of KA,
the physiologic pattern of the hair follicle cycle starts
Fig. 3. Lip epithelium is negative for Periodic acideSchiff
(PAS) staining, K6, and the hair cortex keratin. A, Adjacent
epithelium of KA (H&E, 20). B, Epithelial cells within the
squamous layers of adjacent epithelium are negative for PAS
staining. As expected, the basement membrane is PAS positive
(B, arrows). The ORS of hair follicles is also PAS positive (B,
arrowhead) (PAS,20).C,All epithelial cells are negative for
hair cortex keratin (immunohistochemistry, 20). D, Squa-
mous cell layers do not express K6 (immuno-
histochemistry, 20). E, Squamous cell layers express K10 in
the spinous layer (immunohistochemistry, 20). F,
Basal cell layer of the epithelium expresses K14
(immunohistochemistry, 20).
Table I. Keratin and PAS staining in normal hair fol-
licles and keratoacanthoma
Hair follicle KA Epithelium
A Upper ORS LowerORS Cortex Tumor cells BL SL
PAS þ þ  þ  
AE13   þ   
K6 þ þ  þ  
K10 þ   þ  þ
K14 þ þ  þ þ 
A, antibodies and stains; KA, keratoacanthoma; ORS, outer root
sheath; BL, basal layer; SL, squamous layers; PAS, periodic acide
Schiff stain; K, keratin; e negative; þ positive.
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maturation (catagen phase) and regression (telogen
phase). At the end of the hair cycle, a hair shaft is lost,
and new, specialized layers of epithelial hair follicle are
used to form the new hair and to initiate a new hair
cycle. Disturbances, such as shaving, can trigger the
initiation of a new hair cycle. Mother cells (stem cells)
that are present within the hair follicle bulge and
initially form the ORS and trigger a new hair cycle.
These stem cells are stored along the K14 layer and
contribute to KA.7 In addition, mutations in KA may
stimulate growth, but other active pathways, such as
Wnt signaling, may promote tumor senescence and
regression.7,12In addition to sharing similar biologic behaviors, KA
and the hair follicle cycle also share common hair fol-
licle markers. In this study, we conducted a compre-
hensive analysis of PAS and keratin labeling in both the
normal hair follicle and labial KAs. We showed that the
ORS and infundibulum of the hair follicle was PAS
positive and presented K6, K10, and K14. Interesting,
KA tumor cells exhibited the same biomarkers. In
alignment with our results, other studies showed that
KA cells exhibited K1 and K16, which are keratin pairs
of K10 and K6, respectively. Additionally, KA did not
express other keratins, including K7, K8, K15, K18,
and K19.9,30,31 The presence of the K1 and K10 pair
was in the upper area of the ORS and may be associated
with epithelial maturation once it is expressed in
terminally differentiating epidermal keratinocytes and
infundibular cells,31,32 and K6 and K16 are observed in
hyperproliferative epithelia or the beginning of the ORS
differentiation.31 K14 is frequently present in the pro-
liferative basal layer of stratiﬁed epithelia and hair
follicle cells, such as ORS and stem cells located at the
hair follicle bulge.18,32,33 On the other hand, K7, K8,
and K18 were not observed in KA, probably because
they are mainly associated to simple epithelia.17,18 In
addition, K19 is usually negative for labial epidermis
but positive in the labial mucosa epithelium,17 and
interestingly, it was negative for KA.9,30,31
In addition to the keratins and ORS markers, our
study analyzed markers in the specialized cell layers of
the hair follicle. Hair cortex keratin was observed in the
cortex and precortex of the hair follicle. We found that
hair cortex keratin was absent in KA tumor cells. We
also showed that KA cells were positive for PAS
staining, an important ﬁnding considering that ORS in
the normal hair follicle is also PAS positive.16,34 In
contrast, interfollicular epithelial cells of normal skin
and oral mucosa did not exhibit PAS staining. We found
PAS-positive staining in the majority of tumor cells,
further supporting the role of ORS cells in the histopa-
thology of KA. Like the role of ORS in the new hair
cycle, neoplastic cells of the KA give rise to a prolif-
erative phase and a maturation phase that terminates
during the regression phase. It is likely that ORS cells
acquire mutation(s), probably through sun exposure,
which contributes to the proliferation phase of KA.
PAS-positive stain reveals cells with cytoplasmic
deposits of carbohydrates (e.g., glycogen), glycopro-
teins, and mucopolysaccharides (e.g., mucine). Epithe-
lial cells of skin, particularly the ORS cells of hair
follicles are PAS positive due to their large, glycogen-
rich (clear) cells. The rate of glycogen metabolism
varies in the hair cycle. Growing hair follicles require
more energy compared with resting hair follicles;
therefore, the ORS of hair follicles in the anagen phase
store considerable amounts of glycogen.16,34 Similar to
OOOO ORIGINAL ARTICLE
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trichilemmoma and KA, also store glycogen. Therefore,
PAS stains have been used as helpful markers in as-
sociation with other proteins to differentiate skin tu-
mors.14 Indeed, this is one of the most frequently used
stains in dermatopathology. PAS-positive stains with
diastase aid in the differentiation of trichilemmoma
from sebaceous carcinoma by detailing the glycogen in
the clear cells of trichilemmoma, whereas the clear cells
of sebaceous carcinoma contain lipids. In addition to
helping identify the presence of glycogen versus lipid in
tumor cells, PAS highlights fungal cell walls, and many
PAS-positive inclusion bodies, secretions, and granules,
such as those in the acini of salivary glands, macro-
phages, bronchoalveolar cells, among others.35-37 The
superﬁcial epithelial strata at the junction of the
vermilion and the intermediate zone may display PAS-
positive cells.32 In the skin and oral mucosa, PAS stains
allow the recognition of the basement membrane, which
may be altered in epithelial lesions, such as lichen
planus.38
Numerous studies have analysed the possible mech-
anisms underlying the oncogenesis of KA and SCC or
focusing on how to differentiate these lesions using
histologic criteria, immunohistochemical markers, and
chromosomal abnormalities.4,39-46 Many have consid-
ered immunohistochemistry to be of limited value in the
routine diagnosis of these tumors, and additional
studies are needed. Notably, epidermal growth factor
receptor (EGFR) anomalies appear to be more common
in SCC than in KA, yet immunohistochemical expres-
sion of EGFR has been identiﬁed in both lesions. The
use of EGFR tyrosine kinase inhibitor (i.e., erlotinib),
anti-EGFR antibody (i.e., cetuximab) and retinoic acid,
among others, have shown a positive clinical
response.7,47,48 There are several reports of differential
expression of molecular markers, such as laminin-32,
nuclear factor kappa B/p50, cortactin, glut-1, Bcl-x,
beta-catenin, CD44, anti-P2 X7, K10, E-cadherin,
transforming growth factor-a, peanut agglutinin, peanut
lectin receptor, and carcinoembryonic antigen, in KAs
and SCCs.22,31,40,43,44,49-62
KAs were consistently positive for K6, K10, and
K14. K10 and K14 were observed in specialized cells
within the ORS of the hair follicle and in the inter-
follicular epithelium. As in the normal oral mucosa and
skin, K10 was detected in epithelial spinous layer and
indicated a speciﬁc marker of terminal differentiation.
In ORS, K10-expressing cells were in the upper area of
the hair follicle, anatomically known as the infundib-
ulum. Together, the anatomic location and the K10
expression are associated with epithelial maturation. In
addition, the presence of K10 in KA further indicates
that KA originates from ORS cells, which differentiate
into infundibular cells. K6 was not expressed in theinterfollicular epithelia. K6 was only expressed in ORS
cells, further conﬁrming that KA cells retain ORS cell
markers, indicating its histogenesis. In summary, we
showed that KA neoplastic cells retained the labeling of
K6, K10, and K14, as well as PAS positivity. Collec-
tively, our ﬁndings indicate that KA of the lip is
composed of altered epithelial cells of the hair follicle
that originated from the ORS.
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